Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis
NCT ID: NCT02105818
Last Updated: 2017-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
64 participants
OBSERVATIONAL
2014-03-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380
Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
NCT07182981
Evaluation of Muscle Involvement in Systemic Sclerosis
NCT06051773
Mouth Handicap in Systemic Sclerosis
NCT04273386
Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.
NCT05171114
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The self-report questionnaire is sub-divided into four sections: detection of swallowing difficulties, coping strategies, risk factors to develop swallowing difficulties and adherence to medication.
This study involves patients with systemic sclerosis. Systemic sclerosis often is accompanied by swallowing disorders which may lead to issues in handling medication regimen with risks for patient safety.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Systemic sclerosis
Patients with diagnosed systemic sclerosis treated in the Reha Rheinfelden, Switzerland (European Centre for the Rehabilitation of Scleroderma).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis for systemic sclerosis
* treated in the Reha Rheinfelden
* signed informed consent
* german language skills
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Basel
OTHER
Reha Rheinfelden
OTHER
Kurt Hersberger
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kurt Hersberger
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kurt Hersberger, Prof
Role: STUDY_CHAIR
Pharmaceutical Care Research Group, University of Basel, Switzerland
Markus Messerli, MSc
Role: STUDY_DIRECTOR
Pharmaceutical Care Research Group, University of Basel, Switzerland
Michael Buslau, PD MD
Role: PRINCIPAL_INVESTIGATOR
Reha Rheinfelden, Switzerland
Rebecca Wysser, BSc
Role: PRINCIPAL_INVESTIGATOR
Pharmaceutical Care Research Group, University of Basel, Switzerland
Isabelle Arnet, PhD
Role: PRINCIPAL_INVESTIGATOR
Pharmaceutical Care Research Group, University of Basel, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Reha Rheinfelden
Rheinfelden, Canton of Aargau, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Marquis J, Schneider MP, Payot V, Cordonier AC, Bugnon O, Hersberger KE, Arnet I. Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmacies. Int J Clin Pharm. 2013 Dec;35(6):1130-6. doi: 10.1007/s11096-013-9836-2. Epub 2013 Aug 21.
Schiele JT, Quinzler R, Klimm HD, Pruszydlo MG, Haefeli WE. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. Eur J Clin Pharmacol. 2013 Apr;69(4):937-48. doi: 10.1007/s00228-012-1417-0. Epub 2012 Sep 29.
Related Links
Access external resources that provide additional context or updates about the study.
Homepage of the Pharmaceutical Care Research Group, University of Basel, Switzerland
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SWAMECO_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.